...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Bear a question for you.If I am looking with Rose glasses at the results of Prostate trial and breast cancer trial please correct me.

1 It would seem that theses trials have produced good results.

2 Given 1 why would Pfizer not step up.

3 Could Zen 3694 be sold to more than one BP

Thanks for your thoughts

 

 

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply